Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line

NCT01629875 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

268

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Glabellar Line

Interventions

DRUG: Generic equivalent of Clostridium Botulinum A Toxin
DRUG: Botox (Clostridium Botulinum A Toxin)

Sponsor

Daewoong Pharmaceutical Co. LTD.